NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92 | +3.4% | 155 | 0.0% | 0.00% | – |
| Q2 2023 | $89 | -18.3% | 155 | 0.0% | 0.00% | – |
| Q1 2023 | $109 | -68.9% | 155 | 0.0% | 0.00% | – |
| Q4 2022 | $350 | -65.0% | 155 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 155 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 155 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -66.7% | 155 | -50.5% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 313 | +0.3% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 312 | -0.3% | 0.00% | – |
| Q1 2021 | $6,000 | – | 313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |